DOCSLIB.ORG

ACP Medicine

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ACP Medicine VI DIABETES MELLITUS Saul Genuth, m.d. Classification The classification of diabetes mellitus has recently been re- vised by a task force of the American Diabetes Association that Definition and Overview included representation from Europe.1 Major etiologic classes of Diabetes mellitus is a metabolic disease characterized by hy- the disease, along with more esoteric examples, have been cate- perglycemia that results from defects in insulin secretion, in- gorized [see Table 1]. The vast majority of cases of diabetes melli- sulin action, or both. Important abnormalities in fat and protein tus are either type 1 (insulin-dependent) or type 2 ( non–insulin- metabolism are also present. Nonetheless, the diagnosis still dependent) in an approximate ratio of 1:9. rests upon demonstrating elevated plasma glucose levels. The chronic hyperglycemia of diabetes mellitus is specifically asso- type 1 and type 2 diabetes mellitus ciated with long-term damage, dysfunction, and failure of var- Type 1 and type 2 diabetes were formerly known as insulin- ious organs, especially the retina and lens of the eye, the kid- dependent diabetes mellitus (IDDM) and non–insulin-dependent neys, and both somatic and autonomic nervous systems. The diabetes mellitus (NIDDM), respectively. This classification was heart, arterial system, and microcirculation are also adversely abandoned largely because it was difficult to distinguish patients affected. with IDDM from those patients with NIDDM who eventually re- A variety of pathogenic processes are involved in the devel- quired insulin treatment to mitigate hyperglycemia. Physicians, opment of different forms of diabetes. These processes range nurses, hospital-record-room personnel, health insurers, and from autoimmune destruction of the beta cells of the pancreatic even sometimes researchers were hard put to distinguish be- islets with consequent insulin deficiency to mutations in the in- tween these two forms of diabetes using the old terminology. The sulin receptor gene with consequent resistance to insulin action. new classification, dependent on etiology rather than mode of The basis for the metabolic abnormalities of diabetes mellitus is treatment, puts a greater emphasis on the history and characteris- deficient action of insulin on its major target tissues, including tics of the patients to determine the probable etiology and type. skeletal muscle, cardiac muscle, adipose tissue, and liver. Loss of Two categories of blood glucose elevation, impaired glucose tol- proper insulin regulation of metabolism results from inadequate erance (IGT) and impaired fasting glucose (IFG), that lie between secretion of insulin, from diminished tissue responses to insulin normal glucose levels and overt diabetes have also been estab- at one or more points in the complex pathways of insulin action, lished [see Impaired Glucose Tolerance, below].2 or from both processes. Impairment of insulin secretion and de- fects in insulin action coexist in many patients, and in these pa- gestational diabetes mellitus tients, it is often unclear which abnormality is the primary cause Gestational diabetes mellitus (GDM) constitutes a separate cat- of the hyperglycemia. egory for cases of diabetes first detected during pregnancy.3 When Acute life-threatening consequences of diabetes mellitus are diabetes is detected early in pregnancy, it is likely to be type 1 or ketoacidosis and nonketotic hyperglycemic hyperosmolar coma. type 2 diabetes mellitus that is presenting symptomatically and Overtreatment of hyperglycemia can lead to hypoglycemia, was probably precipitated or worsened by the pregnant state. Di- which may be severe enough to cause seizures and loss of con- abetes is commonly detected in the second and third trimester sciousness. Symptoms of poorly controlled hyperglycemia in- (i.e., in 4% of pregnant women) and is likely to be specific for the clude polyuria, polydipsia, blurred vision, weight loss, polypha- pregnant state, to be transient, and to reverse to normal glucose gia, stunting of growth, and vulnerability to infections or suscep- tolerance or to IGT on follow-up oral glucose tolerance testing 6 tibility to a more virulent or chronic course when infected. weeks after delivery. However, GDM is associated with a high Specific long-term complications of diabetes include (l) risk of future diabetes, especially in women who have IGT post retinopathy with potential loss of vision, (2) nephropathy lead- partum or who remain obese.3 Permanent diabetes will develop in ing to end stage renal disease (ESRD), and (3) neuropathy with approximately 50% of patients within 10 years of GDM. The great- risk of foot ulcers, amputation, Charcot joints, sexual dysfunc- est importance of any single episode of GDM lies in the risks it tion, and potentially disabling dysfunction of the stomach, bow- poses to the fetus. These risks include intrauterine mortality, el, and bladder. Numerous mechanisms have been discovered neonatal mortality, respiratory distress syndrome, hypoglycemia, that may mediate the specific tissue damage caused by hyper- hypocalcemia, jaundice, and macrosomia, which can cause trauma glycemia. Diabetic patients are also at increased risk for athero- such as shoulder dystocia during passage through the birth canal. sclerotic cardiovascular, peripheral vascular, and cerebrovascu- lar disease. These conditions may be related to hyperglycemia as secondary forms of diabetes mellitus well as to hypertension and abnormal lipoprotein profiles that Of the categories of secondary diabetes [see Table 1], endo- are often found in diabetic patients. crinopathies and drug- or chemical-induced diabetes are notewor- Sufficient hyperglycemia to cause pathologic and functional thy because they represent instances of diabetes that are poten- changes in target tissues may be present for some time before tially reversible if they are recognized and the physician can cure clinical symptoms lead to a diagnosis of diabetes in many pa- the endocrinopathy or discontinue the offending drug. The cate- tients. At an even earlier stage, an incipient abnormality in glu- gory of genetic defects in beta cell function illustrates how the cose metabolism can be identified on plasma glucose testing, classification will grow ever more detailed as knowledge increas- which indicates that the patient is at considerably increased risk es. For example, the single diabetes mellitus phenotype formerly for the full clinical disorder. called maturity-onset diabetes of the young (MODY) can now be © 2004 WebMD, Inc. All rights reserved. ACP Medicine May 2004 Update METABOLISM:VI Diabetes Mellitus–1 more precisely classified into at least four genetic varieties, each corticoids is an especially important continuing problem. Up to of which arises from mutation of a different gene. 25% of renal transplant patients develop so-called steroid dia- Diabetes caused by chronic pancreatitis, pancreatectomy, or betes.5 In a case-control study, use of glucocorticoids for up to 45 occasionally carcinoma of the pancreas is usually type 1 in char- days was a risk factor for diabetes that required pharmacologic acter. Because patients with this disease have glucagon as well as treatment.6 The odds ratio rose from 1.77 at a prednisone equiva- insulin deficiency, they are somewhat less likely to go into ke- lent of 10 mg/day to an odds ratio of 10.3 at 30 mg/day. Obesity toacidosis4 but are quite vulnerable to hypoglycemia. Because and family history of diabetes increased the risk of steroid dia- they are deficient in pancreatic enzymes, their digestion and sub- betes. Although insulin resistance in the liver and muscle is a sequent absorption of nutrients is somewhat erratic, even though well-recognized effect of glucocorticoids, an action on the beta replacement enzymes are ingested with meals. If alcoholism, of- cells to limit the compensatory response to hyperglycemia7 adds ten the cause of chronic pancreatitis, is irremediable, it also con- to the diabetogenic effect at higher steroid doses. Patients treated tributes to blood glucose instability, as does the often accompany- with glucocorticoids for more than a few days need to be warned ing irregular lifestyle. Small frequent doses of lispro insulin to watch for and report clinical symptoms of hyperglycemia should be helpful, but safety may require less stringent blood glu- promptly. Ketoacidosis is rare, but hyperglycemic hyperosmolar cose goals in such patients. nonketotic coma can occur. Insulin treatment is usually necessary Although many individual drugs have been incriminated as a for symptomatic patients and for those with a fasting plasma glu- cause of hyperglycemia, the continued use of pharmacologic anti- cose (FPG) level greater than 200 mg/dl, but sulfonylurea drugs inflammatory or immunosuppressive doses of synthetic gluco- are sometimes effective. There is little systematic information on the efficacy of the other oral agents. In most instances, steroid dia- betes is transient, but in a minority of cases, diabetes persists even after withdrawal of the glucocorticoids. Table 1 Etiologic Classification of Diabetes Type 1 diabetes mellitus* (β cell destruction, usually leading to absolute insulin deficiency) Screening for Diabetes Immune mediated Screening for type 1 diabetes mellitus by office glucose testing Idiopathic is currently indicated in high-risk patients. Current American Di- Type 2 diabetes mellitus* (may range from predominantly insulin abetes Association criteria for office screening of asymptomatic
Load more

Recommended publications
  • Shape of Glucose, Insulin, C-Peptide Curves During a 3-H Oral Glucose Tolerance Test: Any Relationship with the Degree of Glucose Tolerance?
    Am J Physiol Regul Integr Comp Physiol 300: R941–R948, 2011. First published January 11, 2011; doi:10.1152/ajpregu.00650.2010. Shape of glucose, insulin, C-peptide curves during a 3-h oral glucose tolerance test: any relationship with the degree of glucose tolerance? Andrea Tura,1 Umberto Morbiducci,2 Stefano Sbrignadello,1 Yvonne Winhofer,3 Giovanni Pacini,1 and Alexandra Kautzky-Willer3 1Metabolic Unit, Institute of Biomedical Engineering, National Research Council, Padova, Italy; 2Department of Mechanics, Politecnico di Torino, Torino, Italy; and 3Department of Internal Medicine III, Division of Endocrinology and Metabolism, Medical University of Vienna, Vienna, Austria Submitted 29 September 2010; accepted in final form 14 January 2011 Tura A, Morbiducci U, Sbrignadello S, Winhofer Y, Pacini G, patients and the investigator. Thus, we expect the OGTT to Kautzky-Willer A. Shape of glucose, insulin, C-peptide curves during a 3-h maintain a relevant role in the study of glucose metabolism. oral glucose tolerance test: any relationship with the degree of glucose Up to now, little attention has been devoted to the possible tolerance? Am J Physiol Regul Integr Comp Physiol 300: R941–R948, 2011. information related to the shape of the concentration time First published January 11, 2011; doi:10.1152/ajpregu.00650.2010.—We courses of the OGTT variables. It is true that the results of aimed to analyze the shape of the glucose, insulin, and C-peptide curves some refined models of ␤-cell function, such as that of the during a 3-h oral glucose tolerance test (OGTT). Another aim was defining an index of shape taking into account the whole OGTT pattern.
    [Show full text]
  • SUPPLEMENTARY DATA APPENDIX 1. Limitations of Hba1c
    SUPPLEMENTARY DATA APPENDIX 1. Limitations of HbA1c What is the relationship between metabolic control and HbA1c? To date, overall glycemic control, as measured by HbA1c, remains the established predictor of diabetes outcomes in persons with type 1 and type 2 diabetes, affecting micro- and macro-vascular complications and mortality. The Diabetes Control and Complications Trial (DCCT), followed by the Epidemiology of Diabetes Interventions and Complications (EDIC) study, demonstrated how elevated HbA1c contributes to complications in T1D (1). The United Kingdom Prospective Diabetes Study (UKPDS) confirmed the importance of glycemic control as well as other components of metabolic control, namely blood pressure, on health outcomes in people with diabetes (2). These studies provided the empiric data that serve as the basis for HbA1c targets recommended by most global organizations. These societies, for the most part, recommend target HbA1c levels of <7% (53 mmol/mol) for adults and <7.5% (58 mmol/mol) for children, although several organizations suggest an HbA1c target of ≤6.5% for adults (AACE) (3) as well as youth (4). All groups suggest aiming for an HbA1c as close to normal as possible without severe hypoglycemia while at the same time indicating a need to individualize glycemic targets according to patient age, duration, co-morbidities, and expected life expectancy with ‘less strict’ HbA1c targets for those less healthy (5). Despite advanced treatment tools, including newer pharmacologic agents (with many classes of oral hypoglycemic agents for T2D), various injectables including long- and short-acting insulin analogs) and advanced technologies (such as insulin pens, insulin pumps, and advanced insulin dosing algorithms for use with pumps or injection regimens), a minority of persons with diabetes, globally, achieve recommended HbA1c levels (6).
    [Show full text]
  • Closing in on the Mechanisms of Pulsatile Insulin Secretion
    Diabetes Volume 67, March 2018 351 Closing in on the Mechanisms of Pulsatile Insulin Secretion Richard Bertram,1 Leslie S. Satin,2 and Arthur S. Sherman3 Diabetes 2018;67:351–359 | https://doi.org/10.2337/dbi17-0004 Insulin secretion from pancreatic islet b-cells occurs in b-cells within islets of Langerhans. Although such rhythms a pulsatile fashion, with a typical period of ∼5min.The are ubiquitous across species, we focus on mice, where most basis of this pulsatility in mouse islets has been inves- of the research on b-cell oscillations has been focused. We tigated for more than four decades, and the various theories anticipate that over the next decade much of what we now have been described as either qualitative or mathematical know about mouse islets will be tested in human islets. models. In many cases the models differ in their mech- Pulsatility in insulin secretion reflects oscillations in the anisms for rhythmogenesis, as well as other less important intracellular Ca2+ concentration of islet b-cells, which in PERSPECTIVES IN DIABETES details. In this Perspective, we describe two main classes of fl 2+ turn re ect bursting electrical activity (5). In intact islets, models: those in which oscillations in the intracellular Ca several types of oscillations are commonly observed. Slow concentration drive oscillations in metabolism, and those oscillations have periods typically between 4 and 6 min (Fig. in which intrinsic metabolic oscillations drive oscillations 1A). Fast oscillations are observed in other islets, with peri- in Ca2+ concentration and electrical activity. We then dis- ods typically less than 1 min (Fig.
    [Show full text]
  • The in Vivo Regulation of Pulsatile Insulin Secretion
    Diabetologia /2002) 45: 3±20 Ó Springer-Verlag 2002 Reviews The in vivo regulation of pulsatile insulin secretion N. Pùrksen1 1 Medical Department of Endocrinology and Metabolism, Aarhus University Hospital, Noerrebrogade, 8000 Aarhus C, Denmark Abstract insulin release have not been reviewed previously. This review will focus on the importance of the secre- The presence of oscillations in peripheral insulin con- tory bursts to overall insulin release, and on how insu- centrations has sparked a number of studies evaluat- lin secretion is adjusted by changes in these secretory ing the impact of the insulin release pattern on the ac- bursts. Detection and quantification of secretory tion of insulin on target organs. These have convinc- bursts depend on methods, and the methodology in- ingly shown that equal amounts of insulin presented volved in studies dealing with pulsatile insulin secre- to target organs have improved action when deliv- tion is described. Finally, data suggest that impaired ered in a pulsatile manner. In addition, impaired pulsatile insulin secretion is an early marker for /not absent) pulsatility of insulin secretion has been beta-cell dysfunction in Type II diabetes, and the demonstrated in Type II /non-insulin-dependent) di- role of early detection of impaired pulsatility to pre- abetes mellitus, suggesting a possible mechanism to dict diabetes or to examine mechanisms to cause explain impaired insulin action in Type II diabetes. beta-cell dysfunction is mentioned. [Diabetologia Whereas the regulation of overall insulin secretion /2002) 45: 3±20] has been described in detail, the mechanisms by which this regulation affects the pulsatile insulin Keywords Insulin, pulsatility oscillation, diabetes, secretory pattern, and the relative and absolute con- physiology, secretion, regulation, C peptide.
    [Show full text]
  • Pulsatile Portal Insulin Delivery Enhances Hepatic Insulin Action and Signaling Aleksey V
    ORIGINAL ARTICLE Pulsatile Portal Insulin Delivery Enhances Hepatic Insulin Action and Signaling Aleksey V. Matveyenko,1 David Liuwantara,1 Tatyana Gurlo,1 David Kirakossian,1 Chiara Dalla Man,2 Claudio Cobelli,2 Morris F. White,3 Kyle D. Copps,3 Elena Volpi,4 Satoshi Fujita,4 and Peter C. Butler1 Insulin is secreted as discrete insulin secretory bursts at ;5-min Insulin secretion is regulated by the magnitude of insulin intervals into the hepatic portal vein, these pulses being attenu- pulses (12,13). Thus, hepatocytes are exposed to an oscil- ated early in the development of type 1 and type 2 diabetes mel- lating insulin concentration wave front with an amplitude of litus (T2DM). Intraportal insulin infusions (pulsatile, constant, or ;0.5–1.0 nmol/L in the fasting state and increasing to ;5.0 reproducing that in T2DM) indicated that the pattern of pulsatile nmol/L after meal ingestion (11,12). The vascular anatomy insulin secretion delivered via the portal vein is important for of hepatic sinusoids permits direct exposure of hepatocytes hepatic insulin action and, therefore, presumably for hepatic in- to these insulin oscillations. sulin signaling. To test this, we examined hepatic insulin signaling Since pulsatile insulin delivery in T1DM and T2DM is in rat livers exposed to the same three patterns of portal vein – insulin delivery by use of sequential liver biopsies in anesthetized impaired (14 16), defective pulsatile insulin delivery may rats. Intraportal delivery of insulin in a constant versus pulsatile contribute to diminished hepatic insulin signaling and he- pattern led to delayed and impaired activation of hepatic insulin patic insulin resistance in diabetes.
    [Show full text]
  • Glucose-Induced Cyclic AMP Oscillations Regulate Pulsatile Insulin Secretion" Cell Metabolism, 2008, Vol
    DiVA *http://uu.diva-portal.org This is an author produced version of a paper published in Cell Metabolism. This paper has been peer-reviewed but does not include the final publisher proof-corrections or journal pagination. Citation for the published paper: Dyachok, Oleg; Idevall-Hagren, Olof; Sågetorp, Jenny; Tian, Geng; Wuttke, Anne; Arrieumerlou, Cécile; Akusjärvi, Göran; Gylfe, Erik; Tengholm, Anders ”Glucose-induced cyclic AMP oscillations regulate pulsatile insulin secretion" Cell metabolism, 2008, Vol. 8, Issue 1: 26-37 URL: http://dx.doi.org/10.1016/j.cmet.2008.06.003 Access to the published version may require subscription. Published with permission from: Elsevier Glucose-induced cyclic AMP oscillations regulate pulsatile insulin secretion Oleg Dyachok1,2, Olof Idevall-Hagren1, Jenny Sågetorp1, Geng Tian1, Anne Wuttke1, Cécile Arrieumerlou3, Göran Akusjärvi4, Erik Gylfe1 and Anders Tengholm1* 1Department of Medical Cell Biology, Uppsala University, Biomedical Centre, Box 571, SE- 751 23 Uppsala, Sweden 2Department of Biophysics, Kiev T. Shevchenko National University, 01033, Kiev, Ukraine 3Infection Biology, Biozentrum, University of Basel, Klingelbergstrasse 50/70, CH-4056, Basel, Switzerland 4Department of Medical Biochemistry and Microbiology, Uppsala University, Biomedical Centre, Box 582, 751 23 Uppsala Running title: Glucose-induced cAMP oscillations in β-cells *Correspondence: Anders Tengholm Department of Medical Cell Biology Uppsala University Biomedical Centre, Box 571 SE-751 23 Uppsala Sweden Phone: +46-18-4714481 Fax: +46-18-4714059 E-mail: [email protected] 1 SUMMARY Cyclic AMP (cAMP) and Ca2+ are key regulators of exocytosis in many cells, including insulin-secreting β-cells. Glucose-stimulated insulin secretion from β-cells is pulsatile and 2+ 2+ involves oscillations of the cytoplasmic Ca concentration ([Ca ]i), but little is known about the detailed kinetics of cAMP signalling.
    [Show full text]
  • Measurement of Pulsatile Insulin Secretion: Rationale and Methodology
    H OH metabolites OH Review Measurement of Pulsatile Insulin Secretion: Rationale and Methodology Marcello C. Laurenti 1,2, Aleksey Matveyenko 1 and Adrian Vella 1,* 1 Division of Endocrinology, Diabetes & Metabolism, Mayo Clinic, Rochester, MN 55905, USA; [email protected] (M.C.L.); [email protected] (A.M.) 2 Biomedical Engineering and Physiology Graduate Program, Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN 55905, USA * Correspondence: [email protected]; Tel.: +1-507-255-6515; Fax: +1-507-255-4828 Abstract: Pancreatic β-cells are responsible for the synthesis and exocytosis of insulin in response to an increase in circulating glucose. Insulin secretion occurs in a pulsatile manner, with oscillatory pulses superimposed on a basal secretion rate. Insulin pulses are a marker of β-cell health, and secretory parameters, such as pulse amplitude, time interval and frequency distribution, are impaired in obesity, aging and type 2 diabetes. In this review, we detail the mechanisms of insulin production and β-cell synchronization that regulate pulsatile insulin secretion, and we discuss the challenges to consider when measuring fast oscillatory secretion in vivo. These include the anatomical difficulties of measuring portal vein insulin noninvasively in humans before the hormone is extracted by the liver and quickly removed from the circulation. Peripheral concentrations of insulin or C-peptide, a peptide cosecreted with insulin, can be used to estimate their secretion profile, but mathematical deconvolution is required. Parametric and nonparametric approaches to the deconvolution problem are evaluated, alongside the assumptions and trade-offs required for their application in the quantifi- Citation: Laurenti, M.C.; cation of unknown insulin secretory rates from known peripheral concentrations.
    [Show full text]
  • Effect of Insulin Sensitivity on Pulsatile Insulin Secretion
    European Journal of Endocrinology (1999) 141 494–501 ISSN 0804-4643 CLINICAL STUDY Effect of insulin sensitivity on pulsatile insulin secretion MilosˇZˇarkovic´, Jasmina C´iric´, Milosˇ Stojanovic´, Zorana Penezic´,Bozˇo Trbojevic´, Milka Drezgic´ and Milica Nesˇovic´ Institute of Endocrinology, School of Medicine, University of Belgrade, Dr Subotic´a 13, 11000 Belgrade, Yugoslavia (Correspondence should be addressed to Milosˇ Zˇarkovic´; Email: [email protected]) Abstract Objective: The aim of the study was to determine whether derangements in insulin pulsatility are related to the presence of insulin resistance or whether these changes occur only in non-insulin- dependent diabetes mellitus (NIDDM). Design and methods: The study included 26 obese, 11 NIDDM and 10 control subjects. The obese group was divided into a low insulin (plasma insulin <20 mU/l, OLI, 14 subjects) and a high insulin (OHI, 12 subjects) group. For pulsatility analysis blood was sampled every 2 min for 90 min. Pulsatility analysis was carried out using the PulsDetekt program. The insulin secretion randomness was quantified using interpulse interval deviation (IpID) and approximate entropy (ApEn). ApEn and ApEn normalized by S.D. of the individual insulin time series (nApEn) were calculated. Lower values of ApEn and IpID indicate more regular secretion. Homeostasis model assessment (HOMA) was used to quantify insulin sensitivity. Results: Insulin pulses were significantly less regular in the OHI and the NIDDM groups compared with the control and the OLI groups (control: ApEn 0.54 6 0.16, nApEn 0.69 6 0.19, IpID 2.53 6 0.99; OLI: ApEn 0.64 6 0.12, nApEn 0.79 6 0.15, IpID 2.92 6 1.09; OHI: ApEn 0.88 6 0.07, nApEn 0.92 6 0.07, IpID 3.95 6 0.84; NIDDM: ApEn 0.92 6 0.16, nApEn 0.99 6 0.09, IpID 4.41 6 0.53; means 6 S.D.).
    [Show full text]
  • Signaling Underlying Pulsatile Insulin Secretion
    Upsala J Med Sci 105: 2,35-5 1,2000 Signaling Underlying Pulsatile Insulin Secretion Erik Gylfe, Meftun Ahmed, Peter Bergsten, HelCne Dansk, Oleg Dyachok, Michael Eberhardson, Eva Grapengiesser, Bo Hellman, Jian-Man Lin, Tea Sundsten, Anders Tengholm, Elaine Vieira and Johanna Westerlund Department of Medical Cell Biology, Uppsala University, Uppsala Sweden Regular oscillations of the circulating insulin concentrations were discovered in the monkey [28] and subsequently found in normal human subjects [50]. The characte- ristic insulin pattern is deteriorated in patients with type 2 diabetes [49] as well as in their close relatives [6 11. Studies in non-diabetic subjects with suppressed endo- genous insulin secretion and diabetic patients have indicated that less insulin is required to maintain normoglycaemia if the hormone is infused in a pulsatile man- ner compared to a constant rate [12, 57, 59, 63, 641. This difference is probably explained by higher expression of insulin receptors, when insulin is delivered in pulses [27]. It is easy to envision a scenario for the development of type 2 diabetes in which deteriorated oscillations leads to insulin resistance with a compensating hypersecretion of the hormone. In susceptible individuals the increased insulin demand may eventually exhaust the pancreatic p-cells with resulting development of overt diabetes. What is then the origin of the regular insulin oscillations? One possibility is that they result from a negative feedback loop between the liver and the pancreatic p- cell [50]. However, later studies have indicated that the oscillations occur indepen- dent of changes in plasma glucose, reflecting a pacemaker function in the pancreas [49, 581.
    [Show full text]
  • Mathematical Modeling and Simulations of the Pathophysiology of Type-2 Diabetes Mellitus Frank K
    Fayetteville State University DigitalCommons@Fayetteville State University Math and Computer Science Working Papers College of Arts and Sciences 10-2015 Mathematical Modeling and Simulations of the Pathophysiology of Type-2 Diabetes Mellitus Frank K. Nani Fayetteville State University, [email protected] Mingxian Jin Fayetteville State University, [email protected] Follow this and additional works at: http://digitalcommons.uncfsu.edu/macsc_wp Part of the Medical Biomathematics and Biometrics Commons Recommended Citation Nani, Frank K. and Jin, Mingxian, "Mathematical Modeling and Simulations of the Pathophysiology of Type-2 Diabetes Mellitus" (2015). Math and Computer Science Working Papers. Paper 25. http://digitalcommons.uncfsu.edu/macsc_wp/25 This Conference Proceeding is brought to you for free and open access by the College of Arts and Sciences at DigitalCommons@Fayetteville State University. It has been accepted for inclusion in Math and Computer Science Working Papers by an authorized administrator of DigitalCommons@Fayetteville State University. For more information, please contact [email protected]. 2015 8th International Conference on BioMedical Engineering and Informatics (BMEI 2015) Mathematical Modeling and Simulations of the Pathophysiology of Type-2 Diabetes Mellitus Frank Nani and Mingxian Jin Department of Mathematics and Computer Science Fayetteville State University Fayetteville, NC 28301, USA Abstract --The pathophysiology of Type 2 Diabetes Mellitus and cardio-metabolic factors. Recent emerging risk factors (T2DM) is modelled using a coupled system of non-linear include sleep deprivation, drug-induced metabolic changes, deterministic differential equations. An attempt is made to environmental pollutants, low birth weight and fetal construct to a clinically plausible mathematical model that malnutrition [3, 4, 5, 6, 7].
    [Show full text]
  • INAUGURAL-DISSERTATION Martina
    Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2006 The effect of feeding time on the quality of metabolic control, day-to-day variability of blood glucose curves and evaluation of IGF-1 levels in cats with diabetes mellitus Alt, Martina Posted at the Zurich Open Repository and Archive, University of Zurich ZORA URL: https://doi.org/10.5167/uzh-163497 Dissertation Published Version Originally published at: Alt, Martina. The effect of feeding time on the quality of metabolic control, day-to-day variability of blood glucose curves and evaluation of IGF-1 levels in cats with diabetes mellitus. 2006, University of Zurich, Vetsuisse Faculty. Aus der Klinik für Kleintiermedizin der Vetsuisse-Fakultät Universität Zürich Direktorin: Prof. Dr. C. Reusch Arbeit unter der Leitung von: Prof. Dr. C. Reusch The effect of feeding time on the quality of metabolic control, day-to-day variability of blood glucose curves and evaluation of IGF-1 levels in cats with diabetes mellitus INAUGURAL-DISSERTATION zur Erlangung der Doktorwürde der Vetsuisse-Fakultät Universität Zürich vorgelegt von Martina Alt Tierärztin von Zollikon, Schweiz genehmigt auf Antrag von Prof. Dr. C. Reusch, Referentin Prof. Dr. T. Lutz, Korreferent Zürich 2006 Für Fredi, Trix und Hans zum Dank für die Grosszügigkeit und U nterstützung 2 Contents Summary …………………………………………………………………………………... 5 PART 1: The effect of feeding time on the quality of metabolic control in diabetic cats…………………………………………………………………………………............. 6 1. Introduction .…………………………………………………………………………….. 6 1.1. Literature...…………………………………………………………………….. 6 1.2. Objectives and Hypothesis…………………………………………………….. 7 2. Materials und Methods...…………………..…………………………………………….. 8 2.1.
    [Show full text]
  • Effectiveness and Safety of Pulsatile Intravenous Insulin Therapy for the Improvement of Respiratory Quotient in Chinese Patients with Diabetes Mellitus
    EXPERIMENTAL AND THERAPEUTIC MEDICINE 19: 3069-3075, 2020 Effectiveness and safety of pulsatile intravenous insulin therapy for the improvement of respiratory quotient in Chinese patients with diabetes mellitus NAN GU1, AIMEI DONG1, LEI GAO2, CHENYING XIE1, PEIYI HOU1, WENBO WANG3, SAINAN ZHU4, CHEN YAO4, JUNQING ZHANG1 and XIAOHUI GUO1 1Department of Endocrinology, 2Institute of Clinical Pharmacology, Peking University First Hospital, Beijing 100034; 3Department of Endocrinology, Peking University Shougang Hospital, Beijing 100144; 4Department of Biostatistics, Peking University First Hospital, Beijing 100034, P.R. China Received May 31, 2019; Accepted December 20, 2019 DOI: 10.3892/etm.2020.8563 Abstract. Pulsatile intravenous insulin therapy (PIVIT) is a Registry (http://www.chictr.org.cn) on November 13th 2019 means of imitating naturally occurring insulin pulses arti- (registration no. ChiCTR1900027510). ficially. It is thought to improve carbohydrate metabolism, which can be assessed using the respiratory quotient (RQ). Introduction The aim of this present study was to assess the efficacy and safety of PIVIT for the improvement of RQ in Chinese patients Insulin secretion occurs in a pulsatile manner into the circula- with diabetes mellitus (DM). This 12‑week, multi‑center, tion of humans and animals, with fast pulses occurring every prospective, randomized, open‑label, parallel‑group study 5‑15 min (1,2). Insulin is secreted into the portal vein and involved 110 DM patients (both type 1 and type 2) whose RQ undergoes partial (40‑80%) hepatic extraction, before being was <0.8. Of these, 53 patients formed the control group, in diluted into the systemic insulin pool. Peripheral insulin which standard anti‑diabetic therapy was maintained, and concentrations oscillate because of the pulsatility of insulin 54 patients formed the treatment group, which underwent secretions (3).
    [Show full text]